Breast Cancer
Articles and resources on breast cancer for patients, caregivers, and family members
Older women with hormone receptor–positive, HER2-negative metastatic breast cancer who are treated with a CDK4/6 inhibitor may derive benefits similar to those seen in their younger counterparts. Read More ›
Treatment with a regimen of pembrolizumab plus trastuzumab in patients with trastuzumab-resistant advanced HER2-positive breast cancer was well-tolerated and had clinical benefit in those whose tumors were positive for a biomarker for pembrolizumab. Read More ›
Patients under age 40 with breast cancer who underwent axillary lymph node dissection were more likely to experience arm swelling and decreased range of arm motion than patients who received less invasive sentinel lymph node biopsies. Read More ›
According to the results of 2 recent analyses, dose-dense or dose-intense chemotherapy reduces the risk for breast cancer recurrence and improves survival compared with standard chemotherapy regimens. Read More ›
For the first time in 40 years, patients who are considering reconstructive surgery after a mastectomy because of breast cancer have a new option for tissue expansion—the AeroForm Tissue Expander System. Read More ›
Read about Verzenio, which was approved by the FDA in 2017, in combination with fulvestrant, for treatment of women with HR-positive, HER2-positive, HER2-negative advanced, or metastatic breast cancer that progressed after endocrine therapy. Read More ›
On July 17, 2017, the FDA approved Nerlynx (neratinib; from Puma Biotechnology) for long-term adjuvant treatment of early-stage, HER2-positive breast cancer in patients who received previous therapy with Herceptin (trastuzumab). Read More ›
Breast cancer survivor Lisa D’Ottavio describes the side effects of treatment that she experienced, from chemo hair loss, neuropathy, and lymphedema, to radiation effects and more. Read More ›
Andrea Brennan, a certified lymphedema therapist, sheds light on the challenges faced with lymphedema associated with breast cancer and debunks several myths about the disease. Read More ›
"My message to other patients is that it is crucial for women diagnosed with breast cancer to be armed with information and to know their treatment options," says Julie Rosenberger. Read More ›